Browsing HMS Scholarly Articles by Keyword "Antiplatelet Therapy"
Now showing items 1-1 of 1
-
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
(Public Library of Science, 2016)Aims Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of 2.0–3.0 for stroke prevention in atrial fibrillation (AF). We ...